Search Within

Immunology Program Faculty

  1. "Ekaterina Doubrovina"
Formats
  1. Meeting Abstract (63)
  2. Journal Article (29)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (94)
  2. Department of Medicine (94)
  3. GSK Faculty (94)
  4. Pediatrics, Department of (94)
  5. Sloan Kettering Institute Faculty (94)
  6. Stem Cell Transplantation and Cellular Therapy Service (94)

More Groups

People
  1. Ekaterina Doubrovina (94)
  2. Richard O'Reilly (94)
  3. Susan Prockop (45)
  4. Aisha Hasan (32)
  5. Guenther Koehne (28)
  6. Mikhail Doubrovin (18)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (7)
  5. 2019 (4)
  6. 2018 (3)

More Years

Publications
  1. Blood (35)
  2. Biology of Blood and Marrow Transplantation (15)
  3. Bone Marrow Transplantation (5)
  4. Cancer Research (5)
  5. Cytotherapy (4)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Elsevier Inc. (18)
  3. American Association for Cancer Research (7)
  4. Nature Publishing Group (7)
  5. Elsevier Science Ltd. (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (94)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Ocular outcomes after treatment of cytomegalovirus retinitis using adoptive immunotherapy with cytomegalovirus-specific cytotoxic t lymphocytes
    Journal Article

    Gupta, M. P.; Koenig, L. R.; Doubrovina, E.; Hasan, A.; Dahi, P. B.; O'Reilly, R. J.; Koehne, G.; Orlin, A.; Chan, R. V. P.; D'Amico, D. J.; more...
    Ophthalmology Retina (2021)

    Fulltext@MSK | Save
  • Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
    Journal Article

    Kyi, C.; Doubrovina, E.; Zhou, Q.; Kravetz, S.; Iasonos, A.; Aghajanian, C.; Sabbatini, P.; Spriggs, D.; O'Reilly, R. J.; O'Cearbhaill, R. E.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4(+) immunity to mediate durable responses
    Journal Article

    Fabrizio, V. A.; Rodriguez-Sanchez, M. I.; Mauguen, A.; Dahi, P. B.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S. E.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after Tab-cel correlates with response & survival in rituximab relapsing or refractory EBV(+) posttransplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Shen, R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Prockop, S.; Doubrovina, E.; O'Reilly, R.; Li, X.; Hiremath, M.; Gamelin, L.; more...
    American Journal of Transplantation (2020)

    Fulltext@MSK | Save
  • Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV plus post-transplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Aftab, B. T.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Prockop, S.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save